Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

BACKGROUND: Antipsychotic monotherapy is recognized as the treatment of choice for patients with schizophrenia. Simultaneous treatment with multiple antipsychotics (polypharmacy) is suggested by some expert consensus guidelines as the last resort after exhausting monotherapy alternatives. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Faries, Douglas, Ascher-Svanum, Haya, Zhu, Baojin, Correll, Christoph, Kane, John
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156914/
https://www.ncbi.nlm.nih.gov/pubmed/15921508
http://dx.doi.org/10.1186/1471-244X-5-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156914/
https://www.ncbi.nlm.nih.gov/pubmed/15921508
http://dx.doi.org/10.1186/1471-244X-5-26

Ejemplares similares